- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
September 17, 2020
In this episode of Px Pulse, the Dapivirine Vaginal Ring is center stage. After decades of research and advocacy, the ring is now one step closer to becoming available as a discreet, woman-initiated HIV prevention option. In July the European Medicines Agency (EMA) issued a positive opinion for the ring, allowing the next steps in the regulatory process to go forward.
Download this podcast to hear five different perspectives on the ring, how it expands HIV prevention options for women, and the most important next steps to bring the ring to women who need it.
Zeda Rosenberg, founder and chief executive officer of the International Partnership for Microbicides (IPM), the ring’s developer, talks about how researchers, implementers and advocates must come together, and the earliest timeline for ring rollout. Cleopatra Makura, a 2019 AVAC Fellow and HIV prevention youth advocate leader in Zimbabwe, talks about what policy makers and young women need for the ring to reach those who need it most. Sharon Hillier, head of the Microbicide Trials Network (MTN), and Benny Kottiri, Research Division Chief in the Office of HIV/AIDS at USAID, remind us what’s remarkable about the ring and underscore the importance of investing in ring introduction and access. And Lori Heise, Professor of Social Epidemiology researcher at the Johns Hopkins Bloomberg School of Public Health and early champion of microbicide research draws lessons from the past that cannot be ignored.
Listen
Highlights
- The ring’s developer, IPM’s Zeda Rosenberg, on next steps for regulatory approval (10:56)
- An advocate, a researcher and a funder, Cleopatra Makura, Sharon Hillier and Benny Kottiri, on what the ring could mean for women (18:38)
- A pioneer in microbicide advocacy, Lori Heise, applies lessons from the past to the work ahead (7:53)
Transcript
Resources
- The International Partnership for Microbicides – IPM
- Understanding the EMA Opinion and Next Steps for the Dapivirine Vaginal Ring – AVAC
- Webinar—Understanding the EMA Opinion: Next Steps for Dapivirine Vaginal Ring – AVAC
- Common Agenda for the Dapivirine Vaginal Ring Introduction – PrEPWatch
- Podcast—Research Fundamentals: What is partial protection? – AVAC
- The PROMISE project: supporting early product introduction planning for the ring